Table 1.
Demographics and clinical characteristics of 7,606 COVID-19 positive patients.
|
Patients characteristics
(n = 7,606) |
Median (IQR)
or count (%)* |
Missing
count (%) |
|---|---|---|
| I. Demographics | ||
| Age (years) | 47 (32–61) | 0 (0%) |
| Sex (Males) | 3,697 (48.6%) | 0 (0%) |
| II. Complete blood count | ||
| White blood cell count (*109/L) | 5.3 (4.3–6.6) | 0 (0%) |
| Neutrophil count (*109/L) | 3.2 (2.4–4.3) | 110 (1.4%) |
| Lymphocyte count (*109/L) | 1.3 (1.0–1.8) | 110 (1.4%) |
| Monocyte count (*109/L) | 0.5 (0.4–0.7) | 110 (1.4%) |
| Hemoglobin (g/dL) | 13.7 (12.6–14.7) | 0 (0%) |
| Hematocrit (L/L) | 0.40 (0.37–0.43) | 1 (<0.1%) |
| Platelet (*109/L) | 214 (173-264) | 5 (<0.1%) |
| III. Liver function | ||
| Albumin (g/L) | 40.0 (37.2–43.5) | 3 (<0.1%) |
| Total bilirubin (μmol/L) | 7.9 (5.8–10.9) | 8 (<0.1%) |
| Alanine aminotransferase (μ/L) | 23.4 (16.0–36.0) | 8 (<0.1%) |
| Alkaline phosphatase (μ/L) | 66 (54–81) | 8 (<0.1%) |
| IV. Kidney function | ||
| Urea (mmol/L) | 3.9 (3.1–4.8) | 5 (<0.1%) |
| Creatinine (μmol/L) | 69.1 (58.0–83.0) | 5 (<0.1%) |
| V. Inflammatory marker | ||
| C-reactive protein | 0.4 (0.1–1.5) | 872 (11.5%) |
| VI. Electrolyte | ||
| Sodium (mmol/L) | 138 (137–140) | 5 (<0.1%) |
| Potassium (mmol/L) | 3.8 (3.5–4.1) | 31 (0.4%) |
| Phosphate (mmol/L) | 1.04 (0.90–1.18) | 2,778 (36.5%) |
| Calcium (mmol/L) | 2.26 (2.18–2.34) | 2,720 (35.8%) |
| VII. Others | ||
| Lactate dehydrogenase (μ/L) | 193.0 (165.0–235.0) | 238 (3.1%) |
| Creatine kinase (μ/L) | 91 (63–143) | 818 (10.8%) |
*
Decimal places were kept according to normal reference range.